[American Thoracic Society American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California - ()] A23. ILD: OUTCOMES AND SELECTED CLINICAL ISSUES - The CAPACITY (CAP) Trials: Randomized, Double-Blind, Placebo-Controlled, Phase III Trials of Pirfenidone (PFD) in Patients with Idiopathic Pulmonary Fibrosis (IPF).

✍ Scribed by Noble, P; Albera, C; Bradford, W; Costabel, U; Kardatzke, D; King, Jr, T; Sahn, S; Szwarcberg, J; Valeyre, D; du Bois, R

• Book ID: 121309375
• Publisher: American Thoracic Society
• Year: 2009
• Weight: 153 KB
• Category: Article
• DOI: 10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A1129